AVANZ Phleum Pratense Immunotherapy

timothy grass pollen immunotherapy · ALK-Abelló A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVANZ Phleum Pratense Immunotherapy, covering 2015-03-06 to 2015-03-06. Get the full timeline:

Most recent: Clinical Trial Update: An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy [Phase 2, Phase 3]